In this interview, Suncoast View welcomes Dr. Sanjay Yathiraj Clinical Trials Director of the Roskamp Institute, to discuss two groundbreaking new therapies available for those diagnosed with Alzheimer’s disease. He also shares insights into the stringent screening process for candidates and the promising future of Alzheimer’s research.
The Roskamp Institute has been at the forefront of Alzheimer’s research for over 30 years, with Dr. Fiona Crawford and Dr. Michael Mullan, co-founders of the Institute, playing key roles in the discovery of the gene that causes Alzheimer’s.
Don’t miss out on this important conversation about keeping Alzheimer’s at bay and maintaining independence for those affected by this devastating disease.
